| Period Ending: | 2027 12-31 |
2026 12-31 |
2025 12-31 |
2024 12-31 |
|---|---|---|---|---|
| Number of Analysts | 0 | 0 | 0 | 0 |
| Estimated Revenue | ||||
| Low | 0 | 0 | 0 | 0 |
| Average | 0 | 0 | 0 | 0 |
| High | 0 | 0 | 0 | 0 |
| Estimated EBITDA | ||||
| Low | 0 | 0 | 0 | 0 |
| Average | 0 | 0 | 0 | 0 |
| High | 0 | 0 | 0 | 0 |
| Estimated EBIT | ||||
| Low | 0 | 0 | 0 | 0 |
| Average | 0 | 0 | 0 | 0 |
| High | 0 | 0 | 0 | 0 |
| Estimated Net Income | ||||
| Low | -1.9 | -2.27 | -2.77 | -28.85 |
| Average | -1.9 | -2.27 | -2.77 | -28.85 |
| High | -1.9 | -2.27 | -2.77 | -28.85 |
| Estimated SGA Expenses | ||||
| Low | 0 | 0 | 0 | 0 |
| Average | 0 | 0 | 0 | 0 |
| High | 0 | 0 | 0 | 0 |
| Estimated EPS | ||||
| Low | -1.62 | -1.93 | -2.36 | -19.02 |
| Average | -1.62 | -1.93 | -2.36 | -19.02 |
| High | -1.62 | -1.93 | -2.36 | -19.02 |
